Anixa Biosciences, Inc. Profile Avatar - Palmy Investing

Anixa Biosciences, Inc.

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell te…

Biotechnology
US, San Jose [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Anixa Biosciences, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of ANIX's Analysis
CIK: 715446 CUSIP: 03528H109 ISIN: US03528H1095 LEI: - UEI: -
Secondary Listings
ANIX has no secondary listings inside our databases.